logo
logo

Cardiomech Raises $13M In Heavily Oversubscribed Round For Its Transcatheter Mitral Chordal Repair Technology

Cardiomech Raises $13M In Heavily Oversubscribed Round For Its Transcatheter Mitral Chordal Repair Technology

01/02/24, 1:02 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/NO.svgtrondheim
Money raised
$13 million
Industry
manufacturing
Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced it has closed on $13M in fresh capital ($42M to-date). CardioMech received strong financial support from existing and new investors, including a non-disclosed strategic investor.

Company Info

Company
CardioMech AS
Location
trondheim, trøndelag, norway
Additional Info
CardioMech develops devices for structural heart disease, offering alternatives to cardiac surgery, specifically for mitral valve issues.

Related People